DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
-2.61%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$43.4B
AUM Growth
-$1.09B
(-2.4%)
Cap. Flow
+$59.4M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
24.12%
Holding
1,560
New
305
Increased
525
Reduced
442
Closed
68
Top Buys
| 1 |
CRH
CRH
|
+$217M |
| 2 |
Meta Platforms (Facebook)
META
|
+$199M |
| 3 |
Exelon
EXC
|
+$99.8M |
| 4 |
MetLife
MET
|
+$89.1M |
| 5 |
Eli Lilly
LLY
|
+$70.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$150M |
| 2 |
Amgen
AMGN
|
+$96.4M |
| 3 |
Applied Materials
AMAT
|
+$73.6M |
| 4 |
Parker-Hannifin
PH
|
+$69.4M |
| 5 |
Microsoft
MSFT
|
+$66.7M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Healthcare | 17.93% |
| 3 | Financials | 10.39% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Alkermes
ALKS
$4.45B
| $1.53M | ﹤0.01% |
54,984
+13,634
| +33% | +$378K |
|
802
Avis
CAR
$5.48B
| $1.52M | ﹤0.01% |
8,440
+422
| +5% | +$76K |
|
803
Sonos
SONO
$1.77B
| $1.51M | ﹤0.01% |
115,000
-5,000
| -4% | -$65.5K |
|
|
PARA
804
DELISTED
Paramount Global Class B
PARA
| $1.5M | ﹤0.01% |
117,515
+12,455
| +12% | +$159K |
|
805
Jackson Financial
JXN
$6.75B
| $1.47M | ﹤0.01% |
39,266
-6,843
| -15% | -$257K |
|
806
Freshworks
FRSH
$3.79B
| $1.47M | ﹤0.01% |
+75,899
| New | +$1.47M |
|
807
Virtu Financial
VIRT
$3.27B
| $1.45M | ﹤0.01% |
84,802
+48,127
| +131% | +$822K |
|
808
HUTCHMED
HCM
$2.7B
| $1.45M | ﹤0.01% |
86,543
| – | – |
|
809
Loews
L
$19.9B
| $1.45M | ﹤0.01% |
22,771
+13
| +0.1% | +$826 |
|
810
RPM International
RPM
$16B
| $1.42M | ﹤0.01% |
14,974
+4,019
| +37% | +$381K |
|
811
Revolution Medicines
RVMD
$7.56B
| $1.42M | ﹤0.01% |
50,000
| – | – |
|
812
Tenable Holdings
TENB
$3.63B
| $1.42M | ﹤0.01% |
32,000
+12,000
| +60% | +$532K |
|
813
Bio-Techne
TECH
$7.93B
| $1.42M | ﹤0.01% |
20,880
+518
| +3% | +$35.1K |
|
814
Ultragenyx Pharmaceutical
RARE
$3.02B
| $1.41M | ﹤0.01% |
40,000
| – | – |
|
815
National Healthcare
NHC
$1.76B
| $1.39M | ﹤0.01% |
21,554
-4,044
| -16% | -$261K |
|
816
Charles River Laboratories
CRL
$7.54B
| $1.38M | ﹤0.01% |
7,097
-611
| -8% | -$119K |
|
817
Liberty Broadband Class C
LBRDK
$8.67B
| $1.38M | ﹤0.01% |
15,118
-3,397
| -18% | -$311K |
|
818
Q2 Holdings
QTWO
$5.13B
| $1.37M | ﹤0.01% |
42,683
+2,683
| +7% | +$85.8K |
|
819
Whirlpool
WHR
$5.24B
| $1.36M | ﹤0.01% |
10,263
-2,352
| -19% | -$312K |
|
820
Denali Therapeutics
DNLI
$2.14B
| $1.36M | ﹤0.01% |
64,210
+4,410
| +7% | +$93.1K |
|
821
Guardant Health
GH
$7.05B
| $1.35M | ﹤0.01% |
45,000
| – | – |
|
822
TFI International
TFII
$7.7B
| $1.35M | ﹤0.01% |
10,424
-969
| -9% | -$125K |
|
823
ANI Pharmaceuticals
ANIP
$2.11B
| $1.34M | ﹤0.01% |
23,022
+3,022
| +15% | +$176K |
|
824
Akero Therapeutics
AKRO
$3.46B
| $1.33M | ﹤0.01% |
27,600
+6,000
| +28% | +$290K |
|
825
Wynn Resorts
WYNN
$12.8B
| $1.33M | ﹤0.01% |
14,630
+2,272
| +18% | +$207K |
|